Methylation of SREBF1, although not in the matched CpG site of our study, affected BMI and was associated with glycemic traits, dyslipidemia, and coronary artery disease in a large set of adult cohorts [59]. The gene discussed is SREBF1; the disease is metabolic syndrome.